PATENT CLAIM ANALYSIS

Application Number: 15905361
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "093400"]

Abstract:
The present invention relates to compositions comprising at least about 8% β-glucans and/or at least about 8% α-fucans, which has a prebiotic effect and act as a replacement for in-feed antibiotics. The present invention also relates to extraction methods to obtain such extracts and various uses for the compositions comprising β-glucans and/or α-fucans.

Claim (Index 20):
A composition comprising:\n at least 8% w/w partially hydrolysed \u03b2-glucans, and/or at least 8% w/w partially hydrolysed \u03b1-fucans, in an effective amount to at least one of: promote the growth of beneficial microbes and reduce the levels of harmful microbes selected from  E. coli  or  Salmonella  in animal or human intestines, improve gut structure, gut inflammation, nutrient digestibility, mineral absorption and growth performance in animals or humans, or act as a replacement for in-feed antibiotics and treatment for gut infection and inflammation, wherein the composition is formulated for oral delivery.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 88.0
- Lexical Diversity: 1.52632
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13321412', '14775206', '14426253', '10487184', '12424145']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6789054965712795
- 35 USC 102 Novelty (BERT): 0.5083090431492177
- Combined Prediction Score: 0.6618458512290734
- Mean Citation Score: 197.69146
- Max Citation Score: 282.64398
- Similarity Product: 210.0197995922792

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test